Propafenone Hydrochloride Patent Expiration

Propafenone Hydrochloride was first introduced by Glaxosmithkline Llc in its drug Rythmol on Nov 27, 1989. Another drug containing Propafenone Hydrochloride is Rythmol Sr. 16 different companies have introduced drugs containing Propafenone Hydrochloride.


Propafenone Hydrochloride Patents

Given below is the list of patents protecting Propafenone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Rythmol Sr US5681588 Delayed release microtablet of β-phenylpropiophenone derivatives Oct 28, 2014

(Expired)

Glaxosmithkline Llc



Propafenone Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Propafenone Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Propafenone Hydrochloride. The first generic version for Propafenone Hydrochloride was by Watson Laboratories and was approved on Oct 24, 2000. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Feb 21, 2023.

Given below is the list of companies who have filed for Propafenone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.